More Mayne Pharma Group Ltd. news
Mayne Pharma Group Ltd.ASX: MYX

S&P DJ Indices Announces March Quarterly Rebalance

Nov 7, 2016 at 12:29 AM EST · Issued by Mayne Pharma Group Ltd.

Filed with ASX · Nov 7, 2016 at 12:29 AM EST · 8 pages · English

On 6ix: 6ix.com/news/sandp-dj-indices-announces-march-quarterly-rebalance-78

Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26↗

Mayne Pharma Group Ltd. on 6ix

In the deck

  • Mayne Pharma Group — UBS Australasia Investor Conference 201616 slidesNov 7, 2016

Earlier from Mayne Pharma

  • MYX launches generic MS Contin (morphine sulfate) tabletsNov 2, 2016
  • IDT: 1st generic proprietary prod shipped to US, temozolomideNov 1, 2016
  • MYX launches generic Entocort EC (Budesonide) capsulesOct 26, 2016
  • Appendix 4E, Directors Report and Financial StatementsAug 25, 2016
  • MYX announces acquisition of US foam dermatology assetsAug 17, 2016

Later from Mayne Pharma

  • Update on Status of DOJ InvestigationDec 15, 2016
  • Mayne Pharma launches Fabior and Sorilux in the USJan 10, 2017
  • Mayne Pharma launches Amiodarone 100mg tabletsJan 12, 2017
  • Mayne Pharma launches Butalbital / APAP tablets in the USFeb 15, 2017
  • 2017 Half Year Media ReleaseFeb 23, 2017
All Mayne Pharma news releases↗

Follow Mayne Pharma into a list and get an email when it puts out news.

Follow Mayne Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer